Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Sell
6,385
-620
-9% -$27.7K 0.01% 281
2026
Q1
$338K Sell
7,005
-100
-1% -$4.66K 0.01% 254
2025
Q4
$344K Hold
7,105
0.01% 255
2025
Q3
$335K Sell
7,105
-989
-12% -$47.7K 0.01% 259
2025
Q2
$391K Sell
8,094
-615
-7% -$31.4K 0.02% 231
2025
Q1
$483K Buy
8,709
+649
+8% +$35.1K 0.02% 196
2024
Q4
$389K Buy
8,060
+665
+9% +$33.8K 0.02% 235
2024
Q3
$426K Hold
7,395
0.02% 215
2024
Q2
$359K Sell
7,395
-805
-10% -$38.8K 0.02% 223
2024
Q1
$399K Sell
8,200
-475
-5% -$23.2K 0.02% 214
2023
Q4
$431K Sell
8,675
-35
-0.4% -$1.71K 0.02% 202
2023
Q3
$467K Sell
8,710
-105
-1% -$5.6K 0.03% 190
2023
Q2
$475K Buy
+8,815
New +$474K 0.03% 189

Other funds holding SNY

D.J. St. Germain's SNY Position: Q2 2026 in Review

D.J. St. Germain reduced its Sanofi (SNY) stake by 8.9% in Q2 2026, selling an estimated $27.7K and leaving 6,385 shares worth $272K. The position accounts for 0.01% of the portfolio, ranked #281.

D.J. St. Germain first reported a position in SNY in Q2 2023 and has held it in 13 quarters since. The position peaked at $483K in Q1 2025. 114 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • D.J. St. Germain held 6,385 shares of Sanofi worth $272K as of Q2 2026.
  • D.J. St. Germain sold 620 Sanofi shares in Q2 2026, an estimated $27.7K.
  • Sanofi made up 0.01% of D.J. St. Germain's portfolio in Q2 2026, its #281 holding.
  • D.J. St. Germain first reported a position in Sanofi in Q2 2023 and has held it in 13 quarters since.
  • D.J. St. Germain's Sanofi position peaked at $483K in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.